 |
American Head & Neck Society
Translational Research Meeting
April 21-22, 2015
AHNS Annual Meeting
April 22-23, 2015 during the
Combined Otolaryngology Spring Meetings
|
Tips on Using this Site
Locate an abstract by entering any author's surname into the search box. You may also search by keyword or program ID number.
Broaden your search by typing only a few letters of a keyword; however, do not append the wildcard “*” to a search string.
Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.
Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.
|
|
|

COSM ABSTRACTS
S002 |
PROGNOSTICATORS OF ONE-YEAR SURVIVAL AFTER SALVAGE SURGERY FOR RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Decisions in Advanced Head and Neck Cancer
Jh Kim1, W G Albergotti, MD2, P A Choi1, D J Kaplan1, S Abberbock3, J T Johnson, MD2, S Kim, MD2, N Gildener-Leapman, MD4
1University of Pittsburgh School of Medicine, 2Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, 3Biostatistics Facility, University of Pittsburgh Cancer Institute, 4Otolaryngology Head and Neck Surgery NYEEI of Mount Sinai
|
S003 |
THE COST OF DYING: HOSPICE UTILIZATION IN TERMINALLY ILL HEAD AND NECK CANCER PATIENTS
Decisions in Advanced Head and Neck Cancer
Laura M Enomoto, MD, MS1, Eric W Schaefer, MS3, David Goldenberg, MD, FACS1, Heath Mackley, MD1, Wayne M Koch, MD2, Christopher S Hollenbeak, PhD3
1Penn State Milton S. Hershey Medical Center, 3Penn State College of Medicine, 2Johns Hopkins University
|
S004 |
TREATMENT OUTCOMES FOR T4 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Decisions in Advanced Head and Neck Cancer
Joseph Zenga, MD, Wilson Michael, BA, Dorina Kallogjeri, MD, MPH, Douglas R Adkins, MD, Hiram A Guy, MD, Bruce H Haughey, MBChB, MS, FACS, FRACS, Randal C Paniello, MD, Jason T Rich, MD, Wade L Thorstad, MD, Nussenbaum Brian, MD
Washington University School of Medicine
|
S005 |
FACTORS ASSOCIATED WITH TREATMENT DELAYS IN ORAL CAVITY SQUAMOUS CELL CARCINOMA AND EFFECT ON SURVIVAL
Decisions in Advanced Head and Neck Cancer
Rance J Fujiwara, BSChm, Benjamin L Judson, MD, Wendell G Yarbrough, MD, Saral Mehra, MD, MBA
Yale School of Medicine
|
S006 |
INHIBITION OF C-MET EFFECTIVELY MITIGATES STROMA-FACILITATED HNSCC PROGRESSION
Experimental Therapeutics/Molecular Targets
Christopher J Kandl, MD, Dhruv Kumar, PhD, Chase Hamilton, BS, Sufi M Thomas, PhD
University of Kansas Medical Center, Department of Otolaryngology Head and Neck Surgery
|
S007 |
IDENTIFICATION OF CIRCULATING TUMOR CELLS IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK PATIENTS AT TIME OF SURGICAL INTERVENTION: LONG-TERM OUTCOMES
Experimental Therapeutics/Molecular Targets
Kyle P McMullen, MD1, Kris R Jatana, MD2, Priya Balasubramanian, PhD3, Jas C Lang, PhD1, Theodoros N Teknos, MD1, David E Schuller, MD1, Jeffrey J Chalmers, PhD3
1Department of Otolaryngology, The Ohio State Wexner Medical Center, 2Department of Pediatric Orolaryngology, Nationwide Childrens Hospital, 3Department of Chemical and Biomolecular Engineering, The Ohio State University
|
S011 |
POST-TREATMENT TUMOR SURVEILLANCE AND PATTERNS OF RECURRENCE DETECTION: TOWARDS DETERMINING AN OPTIMAL FOLLOW UP AND IMAGING PROTOCOL
Outcomes
Ashish Patel, MD, DDS, Yedeh Ying, MD, DMD, Allen Cheng, MD, DDS, Tuan Bui, MD, DMD, Eric Dierks, MD, DMD, R Bryan Bell, MD, DDS
Providence Cancer Center, Portland OR
|
S012 |
FACTORS AFFECTING DELAYS TO RADIATION THERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA, 1998-2011: A REPORT FROM THE NATIONAL CANCER DATA BASE
Outcomes
Erik Liederbach, BS1, Cheryl C Nocon, MD2, Carol M Lewis, MD, MPH3, Chi-Hsiung Wang, PhD1, Arif Shaikh, MD1, Mihir Bhayani, MD1
1NortheShore University HealthSystem, 2University of Chicago School of Medicine, 3University of Texas, MD Anderson Cancer Center
|
S009 |
PIVOTAL PHASE 3 TRIAL RESULTS OF 99MTC-TILMANOCEPT IN SENTINEL LYMPH NODE DETECTION IN ORAL CANCER PATIENTS: COMPARISON OF "SAME DAY" VS "NEXT DAY" IMAGING AND DIAGNOSTIC EFFICACY IN FLOOR OF MOUTH DISEASE
Experimental Therapeutics/Molecular Targets
S Y Lai, MD, PhD1, Amit Agrawal, MD2, Francisco J Civantos, MD3
1University of Texas, MD Anderson Cancer Center, Dept of Head and Neck Surgery, 2The Ohio State University, Wexner Medical Center, Dept of Otolaryngology, 3University of Miami Hospitals and Clinics, Dept. of Otolaryngology
|
S022 |
ANAPLASTIC THYROID CARCINOMA, DOES AGGRESSIVE PALLIATION IMPROVE SURVIVAL?
Endocrine Surgery
Yuval Nachalon, Gideon Bachar, Jacob Shvero, Dror Limon, Aron Popovtzer
Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel
|
|